0000000000937358

AUTHOR

Lysiane Marthey

showing 2 related works from this author

Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study.

2013

International audience; BACKGROUND:: Patients with Crohn's disease (CD) of the colon are at risk for colorectal cancer and should be screened for dysplasia and cancer of the colon. Small bowel adenocarcinoma (SBA) is a complication of small bowel CD and carries a poor prognosis. However, there is no screening test for SBA in patients with small bowel CD. The aim of this study was to assess the risk and incidence of SBA in a large prospective cohort of patients with small bowel CD and to compare it with the risk of colorectal cancer in patients with CD involving the colon, recruited in the same cohort. METHODS:: In a nationwide French cohort, 11,759 patients with CD were enrolled by 680 gast…

AdultMalemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterology03 medical and health sciences0302 clinical medicineCrohn DiseaseInterquartile rangeRisk Factors[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinemedicineImmunology and AllergyHumansProspective StudieseducationProspective cohort studyCrohn's diseaseeducation.field_of_studybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseasePrognosisdigestive system diseasesIleal Neoplasms030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleFrancebusinessColorectal NeoplasmsFollow-Up Studies
researchProduct

Aflibercept in combination with irinotecan, fluorouracil and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal cancer (mCRC) p…

2018

0301 basic medicineOncologymedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseaseIrinotecan03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyFluorouracil030220 oncology & carcinogenesisInternal medicinemedicineFOLFIRIFirst line chemotherapybusinessAfliberceptmedicine.drugAnnals of Oncology
researchProduct